Osaic Holdings
BMRN icon

Osaic Holdings’s BioMarin Pharmaceuticals BMRN Stock Holding History

Osaic Holdings’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$228K Sell
3,982
-446
-10% -$24.4K ﹤0.01% 4319
2026
Q1 		$250K Sell
4,428
-6,525
-60% -$380K ﹤0.01% 3966
2025
Q4 		$651K Buy
10,953
+5,856
+115% +$319K ﹤0.01% 3092
2025
Q3 		$284K Buy
5,097
+33
+0.7% +$1.89K ﹤0.01% 3921
2025
Q2 		$283K Buy
5,064
+1,793
+55% +$106K ﹤0.01% 3646
2025
Q1 		$231K Sell
3,271
-1,175
-26% -$79K ﹤0.01% 3511
2024
Q4 		$210K Buy
4,446
+981
+28% +$65.7K ﹤0.01% 3555
2024
Q3 		$244K Sell
3,465
-1,215
-26% -$102K ﹤0.01% 3496
2024
Q2 		$385K Sell
4,680
-1,834
-28% -$153K ﹤0.01% 2983
2024
Q1 		$569K Sell
6,514
-13,597
-68% -$1.22M ﹤0.01% 2833
2023
Q4 		$1.94M Sell
20,111
-3,481
-15% -$308K ﹤0.01% 1885
2023
Q3 		$2.09M Buy
23,592
+8,077
+52% +$719K ﹤0.01% 1952
2023
Q2 		$1.34M Sell
15,515
-2,615
-14% -$246K ﹤0.01% 2215
2023
Q1 		$1.76M Buy
18,130
+784
+5% +$81.3K ﹤0.01% 1928
2022
Q4 		$1.8M Sell
17,346
-177
-1% -$16.6K ﹤0.01% 1830
2022
Q3 		$1.49M Sell
17,523
-237
-1% -$21.1K ﹤0.01% 1865
2022
Q2 		$1.47M Sell
17,760
-3,827
-18% -$305K ﹤0.01% 1911
2022
Q1 		$1.64M Sell
21,587
-2,208
-9% -$185K ﹤0.01% 2104
2021
Q4 		$2.1M Buy
23,795
+46
+0.2% +$3.8K ﹤0.01% 1739
2021
Q3 		$1.83M Buy
23,749
+342
+1% +$27K ﹤0.01% 1781
2021
Q2 		$1.95M Buy
23,407
+1,126
+5% +$89.3K ﹤0.01% 1747
2021
Q1 		$1.67M Buy
22,281
+3,325
+18% +$272K ﹤0.01% 1762
2020
Q4 		$1.66M Buy
18,956
+2,645
+16% +$210K ﹤0.01% 1597
2020
Q3 		$1.25M Sell
16,311
-2,988
-15% -$302K ﹤0.01% 1655
2020
Q2 		$2.38M Buy
19,299
+3,937
+26% +$391K 0.01% 1153
2020
Q1 		$1.3M Buy
+15,362
New +$1.32M 0.01% 1334

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Osaic Holdings's BMRN Position: Q2 2026 in Review

Osaic Holdings reduced its BioMarin Pharmaceuticals (BMRN) stake by 10% in Q2 2026, selling an estimated $24.4K and leaving 3,982 shares worth $228K. The position accounts for ﹤0.01% of the portfolio, ranked #4319.

Osaic Holdings first reported a position in BMRN in Q1 2020 and has held it in 26 quarters since. The position peaked at $2.38M in Q2 2020. 565 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • Osaic Holdings held 3,982 shares of BioMarin Pharmaceuticals worth $228K as of Q2 2026.
  • Osaic Holdings sold 446 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $24.4K.
  • BioMarin Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #4319 holding.
  • Osaic Holdings first reported a position in BioMarin Pharmaceuticals in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's BioMarin Pharmaceuticals position peaked at $2.38M in Q2 2020.
  • 565 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.